Cabot - CBT Stock Forecast, Price & News

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Cabot in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" CBT shares.
View CBT analyst ratings or view top-rated stocks.

2 equities research analysts have issued 12-month price objectives for Cabot's stock. Their CBT share price forecasts range from $85.00 to $90.00. On average, they expect the company's stock price to reach $87.50 in the next twelve months. This suggests a possible upside of 16.6% from the stock's current price.
View analysts price targets for CBT or view top-rated stocks among Wall Street analysts.

Cabot's stock was trading at $56.20 at the beginning of the year. Since then, CBT stock has increased by 33.5% and is now trading at $75.02.
View the best growth stocks for 2022 here.

Cabot saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 1,190,000 shares, a decrease of 16.8% from the October 31st total of 1,430,000 shares. Based on an average trading volume of 355,700 shares, the short-interest ratio is presently 3.3 days. Approximately 2.1% of the shares of the company are sold short.
View Cabot's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, January 30th 2023.
View our CBT earnings forecast.

Cabot Co. (NYSE:CBT) issued its earnings results on Sunday, November, 7th. The specialty chemicals company reported $1.11 earnings per share for the quarter, beating the consensus estimate of $1.03 by $0.08. The specialty chemicals company had revenue of $904 million for the quarter, compared to analyst estimates of $914.88 million. Cabot had a net margin of 4.84% and a trailing twelve-month return on equity of 35.30%. The business's quarterly revenue was up 37.2% compared to the same quarter last year. During the same quarter last year, the firm earned $0.68 earnings per share.

Cabot announced a quarterly dividend on Thursday, November 10th. Investors of record on Friday, November 25th will be given a dividend of $0.37 per share on Friday, December 9th. This represents a $1.48 annualized dividend and a dividend yield of 1.97%. The ex-dividend date is Wednesday, November 23rd.
Read our dividend analysis for CBT.

Cabot (NYSE:CBT) pays an annual dividend of $1.48 per share and currently has a dividend yield of 2.00%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 41.11%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CBT will have a dividend payout ratio of 24.38% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CBT.

Cabot issued an update on its FY 2023 earnings guidance on Monday, November, 21st. The company provided earnings per share (EPS) guidance of $6.25-$6.75 for the period, compared to the consensus EPS estimate of $6.97. The company issued revenue guidance of -.

40 employees have rated Cabot Chief Executive Officer Sean Keohane on Glassdoor.com. Sean Keohane has an approval rating of 96% among the company's employees. This puts Sean Keohane in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cabot investors own include Pfizer (PFE), Broadcom (AVGO), Energy Transfer (ET), AT&T (T), Gilead Sciences (GILD), Intel (INTC), NVIDIA (NVDA), Advanced Micro Devices (AMD), Cisco Systems (CSCO) and Coca-Cola (KO).

Cabot trades on the New York Stock Exchange (NYSE) under the ticker symbol "CBT."

Cabot's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (12.06%), Vanguard Group Inc. (10.97%), State Street Corp (3.21%), Dimensional Fund Advisors LP (2.84%), Bank of New York Mellon Corp (1.55%) and LSV Asset Management (1.39%). Insiders that own company stock include Hobart Kalkstein, Karen A Kalita, Karen A Kalita and Sean D Keohane.
View institutional ownership trends.

Shares of CBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CBT stock can currently be purchased for approximately $75.02.

Cabot (NYSE:CBT) has a market capitalization of $4.23 billion and generates $4.32 billion in revenue each year. The specialty chemicals company earns $209 million in net income (profit) each year or $3.60 on an earnings per share basis.

The company employs 4,200 workers across the globe.

Cabot's mailing address is TWO SEAPORT LANE SUITE 1300, BOSTON MA, 02210. The official website for the company is www.cabot-corp.com. The specialty chemicals company can be reached via phone at (617) 345-0100, via email at steve.delahunt@cabotcorp.com, or via fax at 617-342-6103.